Pet Pheromone Therapy Market Forecasts to 2034 - Global Analysis By Product Type (Diffusers, Sprays, Collars, Wipes and Other Delivery Formats), Animal Type, Application, Distribution Channel, and By Geography

According to Stratistics MRC, the Global Pet Pheromone Therapy Market is accounted for $1.4 billion in 2026 and is expected to reach $2.4 billion by 2034 growing at a CAGR of 7% during the forecast period. Pet pheromone therapy involves the use of synthetic analogues of naturally occurring animal pheromones to support behavioral management and reduce stress-related behaviors in companion animals. The market encompasses diffusers, sprays, collars, wipes, and other delivery formats designed primarily for dogs and cats. These products are used to address anxiety, stress, urine marking, scratching, noise-related distress, travel anxiety, and behavioral conflicts in multi-pet households. Increasing awareness of animal welfare, growing pet humanization, and the adoption of non-pharmaceutical behavioral management solutions are supporting demand across veterinary clinics, pet specialty stores, online retail platforms, and other distribution channels.

Market Dynamics:

Driver:

Growing awareness of pet anxiety and behavioral health

Increasing awareness of companion animal behavioral health is a primary driver for the pet pheromone therapy market. Pet owners are increasingly seeking solutions to manage anxiety, fear, territorial marking, excessive scratching, and stress associated with environmental changes. Pheromone-based products provide a non-pharmaceutical option that can complement behavioral training and veterinary guidance. Moreover, growing pet humanization is encouraging owners to invest in products that improve animal comfort and household harmony. Adoption-related stress, separation anxiety, loud noises, travel, and the introduction of new animals can create demand for targeted calming solutions. As veterinary professionals and pet care providers emphasize behavioral well-being, pheromone therapy products are gaining recognition in companion animal care.

Restraint:

Variable product effectiveness and limited consumer understanding

Variability in behavioral responses and limited consumer understanding can constrain the adoption of pet pheromone therapy products. The effectiveness of pheromone-based solutions may differ according to the animal, behavioral condition, environmental factors, and product formulation. Some pet owners may expect immediate or universal results, leading to dissatisfaction when behavioral improvements are gradual or incomplete. Additionally, consumers may have difficulty distinguishing pheromone-based products from supplements, herbal calming products, and other behavioral management solutions. In cases involving severe anxiety, aggression, or persistent behavioral disorders, pheromone therapy alone may not address the underlying problem. These factors can affect repeat purchases and reinforce the importance of veterinary guidance, clear product communication, and appropriate behavioral management practices.

Opportunity:

Innovation in long-lasting formulations and targeted pheromone solutions

Advancements in pheromone formulations and product delivery technologies present opportunities for market expansion. Manufacturers are developing products designed to provide extended release, improve convenience, and address specific behavioral needs in dogs and cats. Electric-free gel diffusers, portable sprays, collars, and multi-animal household solutions can broaden product accessibility across different environments. Moreover, growing demand for solutions addressing multi-cat tension, travel-related distress, noise sensitivity, and adjustment to new surroundings creates opportunities for specialized formulations. E-commerce platforms and veterinary distribution networks can improve product awareness and accessibility. As manufacturers invest in research, clinical evaluation, and educational initiatives, targeted pheromone therapies can strengthen their position within preventive behavioral care and companion animal wellness.

Threat:

Competition from alternative calming products and behavioral interventions

Competition from alternative pet calming products represents a significant threat to the pet pheromone therapy market. Consumers can choose from nutritional supplements, calming treats, herbal formulations, pressure garments, environmental enrichment products, and professional behavioral services. These alternatives may appeal to consumers seeking different delivery formats, price points, or perceived benefits. Additionally, the presence of multiple products with similar claims can make it difficult for consumers to assess differences in effectiveness and suitability. Regulatory requirements governing product claims, ingredient safety, and veterinary recommendations can also affect commercialization strategies across markets. Manufacturers must therefore differentiate their products through credible evidence, clear usage guidance, reliable quality, and effective distribution partnerships.

Covid-19 Impact:

The COVID-19 pandemic influenced the pet pheromone therapy market through changes in pet ownership, household routines, and animal behavior. Increased time spent at home encouraged pet adoption and greater attention to companion animal well-being. However, changes in daily routines, reduced socialization, and the subsequent return to workplaces created behavioral challenges for some animals, including separation-related distress. Veterinary access restrictions and retail disruptions affected product availability in certain markets, while e-commerce channels provided alternative purchasing options. Following the pandemic, continued interest in pet behavioral health and preventive care has supported demand for calming solutions. Veterinary consultations, behavioral education, and convenient product formats continue to influence adoption across household and professional settings.

The Diffusers segment is expected to account for the largest share during the forecast period

The Diffusers segment is expected to account for the largest share of the pet pheromone therapy market, supported by demand for convenient, continuous delivery of calming pheromone analogues within household environments. Plug-in diffusers and refill systems are widely suited to managing stress associated with changes in surroundings, territorial behavior, and tension among cats sharing the same home. These products allow pheromones to be dispersed within designated living spaces without requiring repeated manual application. Established product ranges, including feline calming diffusers and multi-cat formulations, further support consumer familiarity. Additionally, recurring refill purchases can contribute to continued demand. The availability of dog-oriented calming diffusers also expands the category's application across companion animal households.

The Sprays segment is expected to witness strong growth during the forecast period

The Sprays segment is expected to witness strong growth as pet owners seek portable and flexible solutions for managing situational stress. Pheromone sprays can be applied to appropriate environmental surfaces, carriers, bedding, and other specified areas, making them useful during travel, veterinary visits, temporary environmental changes, and other stressful situations. Their portability and ease of application can appeal to consumers who do not require continuous household diffusion. Moreover, sprays can complement broader behavioral management approaches and provide an alternative where electrical diffusers are impractical. Product innovation, improved retail availability, and increasing awareness of travel-related pet stress are expected to support the segment's growth during the forecast period.

Region with largest share:

During the forecast period, North America is expected to hold the largest share of the Global Pet Pheromone Therapy Market, supported by established companion animal care practices, broad availability of specialized pet products, and a developed veterinary distribution network. The United States represents a major market for pet behavioral management products, with established brands offering pheromone-based diffusers, sprays, collars, and related calming solutions. Strong e-commerce infrastructure and the presence of pet specialty retailers improve product accessibility. Additionally, growing attention to pet anxiety, multi-cat household conflicts, and behavioral wellness supports demand for specialized products. Veterinary recommendations and consumer familiarity with established pheromone brands further contribute to regional market development.

Region with highest CAGR:

Over the forecast period, Asia Pacific is expected to exhibit the highest CAGR, driven by expanding companion animal ownership, urbanization, improving access to veterinary services, and growing consumer interest in specialized pet care. Rising awareness of animal behavioral health is creating opportunities for calming products among pet owners in China, Japan, India, South Korea, and Australia. The expansion of e-commerce platforms and pet specialty retail channels is improving access to imported and domestically marketed products. Moreover, compact living environments and changing household routines can increase interest in solutions for stress associated with environmental changes and multi-pet interactions. Continued investment in pet care education and product distribution is expected to support regional growth.

Key players in the market

Some of the key players in the Global Pet Pheromone Therapy Market include Ceva Sante Animale, Central Garden & Pet Company, Pet Remedy Limited, Beaphar B.V., Virbac S.A., Vetoquinol S.A., ADAPTIL, FELIWAY, PetSafe (Radio Systems Corporation), ThunderWorks, Nutri-Vet, Vetnique Labs, Earth Animal, Boehringer Ingelheim Animal Health, and Pets at Home Group Plc.

Key Developments:

In June 2026, Central Garden & Pet Company's Comfort Zone brand introduced Cat Calming Mousse, expanding its cat calming portfolio with a health supplement designed to help manage everyday stress. The launch complements the company's existing range of calming diffusers, refills, collars, and sprays, reflecting continued product diversification in companion animal behavioral care.

In March 2026, FELIWAY strengthened its commitment to feline welfare through a partnership initiative with France's Societe Protectrice des Animaux (SPA). The campaign supported animal welfare by directing contributions toward the feeding and care of cats in shelters through purchases of FELIWAY Optimum diffusers and refills at participating veterinary clinics.

In February 2026, Virbac introduced its ZENIFEL and ZENIDOG pheromone product ranges in Spain, featuring long-lasting gel diffusers and additional delivery formats for cats and dogs. The new solutions include electric-free gel diffusers designed for extended use, alongside spray and collar options intended to help manage stress-related behaviors.

In February 2026, FELIWAY marked its 30th anniversary, highlighting three decades of feline behavioral research and pheromone-based product development. The milestone reinforced the brand's position in cat behavioral wellness and its established portfolio of diffusers, sprays, and other products designed to help manage stress-related behaviors.

Product Types Covered:

• Diffusers
• Sprays
• Collars
• Wipes and Other Delivery Formats

Animal Types Covered:

• Dogs
• Cats
• Other Companion Animals

Applications Covered:

• Anxiety and Stress Management
• Urine Marking and Scratching
• Noise and Travel-Related Stress
• Multi-Pet Conflict and Behavioral Adjustment

Distribution Channels Covered:

• Veterinary Clinics and Hospitals
• Pet Specialty Stores
• Online Retail
• Other Retail Channels

Regions Covered:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
  • Belgium
  • Sweden
  • Switzerland
  • Poland
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Malaysia
  • Singapore
  • Vietnam
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Colombia
  • Chile
  • Peru
  • Rest of South America
• Rest of the World (RoW)
  • Middle East
    • Saudi Arabia
    • United Arab Emirates
    • Qatar
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • Egypt
    • Morocco
    • Rest of Africa

What our report offers:

• Market share assessments for regional and country-level segments
• Strategic recommendations for new entrants
• Covers market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032, and 2034
• Market trends, including drivers, constraints, opportunities, threats, challenges, investment opportunities, and recommendations
• Strategic recommendations for key business segments based on market estimations
• Competitive landscape mapping and assessment of key industry trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends and assessment of the latest technological advancements

Free Customization Offerings:

All customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, forecasts, and CAGR of any prominent country as per the client's interest (subject to feasibility assessment)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances